No description
-
2018 (v1)PublicationUploaded on: April 14, 2023
-
2019 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2018 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2016 (v1)Publication
A possible side effect of anticancer treatments in premenopausal women is the occurrence of premature ovarian failure and subsequent infertility. The inheritance of a deleterious genetic mutation in the BRCA1 or 2 genes generates the hereditary breast and ovarian cancer syndrome. Additional fertility counseling for breast cancer patients with...
Uploaded on: April 14, 2023 -
2021 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2016 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2018 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2014 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2018 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2018 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2019 (v1)Publication
Triple-negative breast cancer (TNBC) is associated with a high risk of recurrence and generally a bad prognosis. More than one-third of patients with TNBC will present distant metastases during the course of their disease. Although chemotherapy has been the main treatment option for metastatic TNBC for a long time, this scenario has changed...
Uploaded on: April 14, 2023 -
2018 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2022 (v1)Publication
No description
Uploaded on: February 14, 2024 -
2019 (v1)Publication
PURPOSE OF REVIEW: This manuscript aims at providing an updated overview on the role of adding ovarian function suppression to tamoxifen or an aromatase inhibitor as adjuvant endocrine therapy in premenopausal women with estrogen receptor-positive early breast cancer. RECENT FINDINGS: Until recently, tamoxifen alone was the only recommended...
Uploaded on: April 14, 2023 -
2018 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2015 (v1)Publication
The last decade has witnessed important advances in the field of managing cancer during pregnancy. However, still limited data is available on the safety of administering targeted agents in pregnant cancer patients. Given the increasing use of targeted agents in clinical practice, it is becoming vital to properly understand how far they can be...
Uploaded on: April 14, 2023 -
2019 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2016 (v1)Publication
Over the past 20...years, the prognosis of HER2-positive breast cancer has been transformed by the development of anti-HER2 targeted therapies. In early clinical trials of trastuzumab (ie, the first anti-HER2 agent to be developed) cardiotoxicity became a major concern. In the first published phase 3 trial of trastuzumab, 27% of patients...
Uploaded on: April 14, 2023 -
2015 (v1)Publication
PURPOSE OF REVIEW: The purpose of the article is to review the available options for fertility preservation in patients with breast and ovarian cancer, and the special issues faced by BRCA mutation carriers. RECENT FINDINGS: Future fertility is an important consideration for many young patients with cancer. There are both experimental and...
Uploaded on: April 14, 2023 -
2017 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2019 (v1)Publication
A complete oncofertility counselling should be offered to all premenopausal patients before the administration of anticancer treatments. This important discussion is a crucial step for allowing them to take fully informed decisions about the proposed therapy and its potential long-term consequences as well as on their need and interest of...
Uploaded on: April 14, 2023 -
2019 (v1)Publication
The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help...
Uploaded on: April 14, 2023